Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
12.20
+0.44 (3.74%)
Oct 14, 2025, 3:18 PM EDT
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $19.45 million as of October 15, 2025. Its market cap has increased by 701.98% in one year.
Market Cap
19.45M
Enterprise Value
32.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.20
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 19.45M, a decrease of -98.07%. That is a compound annual growth rate of -57.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 19.45M | 7.17% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |